Nipro Corporation (5FA.F)
Frankfurt · EUR · Healthcare · Medical Instruments & Supplies
€7.55 (+0.67%) as of
Key statistics
- Market cap
- 1.23B
- P/E (TTM)
- 17.56
- EPS (TTM)
- 0.43
- Dividend yield
- 2.27%
- 52-week range
- 7.20 – 9.25
- Beta
- -0.00
- Revenue (TTM)
- 668.86B
- Profit margin
- 2.10%
- Volume
- 4.80k
About Nipro Corporation
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc. It also provides cardiopulmonary products comprising oxygenators, cardioplegia heat exchangers, perfusion tubing sets, arterial filters, hemoconcentrators, and venous and arterial cannulae; and enzymes, as well as contract development and manufacturing services. In addition, the company offers pharmaceutical combination products consisting of dual chamber bags, pre-filled syringes, and half-type kits; and integrated services, such as development, manufacturing, inspection, and packaging. Further, it provides glass containers, rubber stoppers, glass tubes, and other supplies for medical use; supplies for other industries; and drug administration systems, as well as autologous bone-marrow mesenchymal stem cells, culture products, and cell preservation products. The company was founded in 1947 and is headquartered in Settsu, Japan.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Settsu, Japan
- Employees
- 38,593
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.